Search results
What Should You Do If You Miss a Dose of Anti-Obesity Medication?
Verywell Health via Yahoo News· 5 days agoWith shortages continuing, many that have found success with new anti-obesity medications are having...
EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's IND Gains FDA...
Benzinga via Yahoo Finance· 7 days agoVivani Medical, Inc. (NASDAQ:VANI) announced that the U.S. FDA has cleared its Investigational New...
Novo’s blockbuster obesity drug Wegovy under fire in Denmark
Detroit News· 7 days agoA Danish drug oversight panel advised doctors to restrict prescriptions of Novo Nordisk A/S’s...
Two Is Better Than One in the Alzheimer’s Market
The Wall Street Journal via Yahoo Finance· 3 days agoThe FDA is expected to decide on whether to approve the drug by the end of the year. Life expectancies around the world have surged in recent...One might...
3 Stocks to Buy as Ozempic Surges in Popularity
InvestorPlace via Yahoo Finance· 7 days agoOzempic and Wegovy (semaglutide for diabetes and weight loss, respectively) are popular weight-loss drugs that have taken the world by storm. Indeed, the...
Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster | The Motley Fool
The Motley Fool· 5 days agoEli Lilly's (LLY -0.55%) name has become somewhat synonymous with its work in diabetes and obesity...
...'s Type 2 Diabetes Treatment NPM-119 Subdermal Implant's IND Gains FDA Clearance For Clinical Use...
Benzinga· 7 days agoVivani Medical, Inc. VANI announced that the U.S. FDA has cleared its Investigational New Drug Application for NPM-119, paving the way for the commencement of the LIBERATE ...
Could Structure Therapeutics Become the Next Novo Nordisk?
Motley Fool via Yahoo Finance· 3 days agoThe catch is that Structure is still toward the beginning of its life as a biotech. It hasn't yet...
Scammers make millions selling nonexistent Ozempic, report finds
Newsweek· 6 days agoWeight-loss drugs are in high demand, and scammers are cashing in on the craze. Phishing attempts...
Gateway - Quartz
Quartz· 2 days agoThe world’s largest company for diabetes treatments alleges illegal marketing and sales practices by third-parties “created a high risk of consumer confusion and deception as well as potential ...
